THERESA WOODARD: Open Payments
NPI 1528342730 · BLOOMINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,502 in 140 payments from 25 companies in 2025. Trend: 2023 $2,594 · 2024 $2,117 · 2025 $2,502
Food & beverage: $2,502
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $379 |
| Amgen Inc. | 22 | $367 |
| ABBVIE INC. | 35 | $352 |
| Novo Nordisk Inc | 15 | $342 |
| PFIZER INC. | 11 | $192 |
| Novartis Pharmaceuticals Corporation | 12 | $168 |
| Verona Pharma, Inc. | 6 | $113 |
| JAZZ PHARMACEUTICALS INC. | 3 | $87 |
| Astellas Pharma US Inc | 3 | $73 |
| Vanda Pharmaceuticals Inc. | 2 | $55 |
Products named: BREZTRI, Wegovy, RINVOQ, LEQVIO, AIRSUPRA, OTEZLA, Ozempic, Ohtuvayre.
Industry payments across IN — which companies pay providers there.
